ARWR
Arrowhead Pharmaceuticals Inc
65.90$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -155.4% | – | -179.5% | – | – | – | |
| – | +73.6% | +39.5% | +43.9% | +0.2% | -5.5% | +33.9% | +39.1% | +26.1% | +19.9% | +48.8% | +28.7% | |
| – | +79.6% | +13.3% | -31.9% | +7.1% | +46.6% | +250.1% | +76.7% | +57.7% | -35.4% | -5.3% | -14.3% | |
| – | +37.6% | -58.3% | -13.4% | +14.6% | +67.8% | +222.3% | +76.7% | +63.5% | -27.8% | – | – | |
| – | -31.9% | +67.8% | -121.1% | – | – | -170.1% | – | -143.0% | – | – | -172.7% | |
| – | +14.7% | +95.9% | +105.1% | -82.1% | +744.4% | -0.4% | +97.2% | +123.9% | +234.9% | -20.0% | -84.0% | |
| – | – | -4.8% | -461.7% | -84.7% | +542.2% | +404.3% | -41.2% | -96.2% | +1,675.1% | +336.9% | -69.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.7% | -225.7% | -30.8% | -87.5% | – | +274.9% | -95.6% | -54.1% | – | – | – | |
| – | -5.1% | +1.7% | -9.1% | +5.4% | +1,058.3% | – | +0.0% | +0.0% | +0.0% | +56.8% | -148.8% | |
| – | -99.8% | +18,876.9% | -78.1% | +397.3% | +10.7% | +288.6% | -95.6% | +476.6% | +288.2% | +244.0% | -91.5% | |
| – | -145.2% | – | -1,557.8% | – | +3,520.1% | -140.8% | – | -287.1% | – | -384.3% | – | |
| – | – | – | – | – | – | -166.9% | – | -227.9% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.